Literature DB >> 1745285

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome.

R P Kleyweg1, F G van der Meché, P I Schmitz.   

Abstract

In studies of Guillain-Barré syndrome, functional deficit is usually assessed according to a functional scale consisting of several categories. The level of interobserver agreement in this scoring method is not known; furthermore, this method seems to be insensitive when applied to bedridden and artificially ventilated patients. We have developed an additional score (MRC-sumscore), reflecting muscle strength in general. Both scoring methods, tested in Guillain-Barré patients, have an almost perfect interobserver agreement. For the functional score kappa = 0.85, and for the MRC-sumscore r2 = 0.96. The MRC-sumscore is easily assessed and more sensitive than the functional score when patients are bedridden or artificially ventilated.

Entities:  

Mesh:

Year:  1991        PMID: 1745285     DOI: 10.1002/mus.880141111

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  203 in total

1.  Physical therapy management and patient outcomes following ICU-acquired weakness: a case series.

Authors:  Amy Nordon-Craft; Margaret Schenkman; Kyle Ridgeway; Alexander Benson; Marc Moss
Journal:  J Neurol Phys Ther       Date:  2011-09       Impact factor: 3.649

2.  Neurally adjusted ventilatory assist in patients with critical illness-associated polyneuromyopathy.

Authors:  Daniel Tuchscherer; Werner J Z'graggen; Christina Passath; Jukka Takala; Christer Sinderby; Lukas Brander
Journal:  Intensive Care Med       Date:  2011-11-03       Impact factor: 17.440

3.  Nerve ultrasound in the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis with predominant lower motor neuron disease (ALS/LMND).

Authors:  Kai F Loewenbrück; Julia Liesenberg; Markus Dittrich; Jochen Schäfer; Beate Patzner; Beate Trausch; Jochen Machetanz; Andreas Hermann; Alexander Storch
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

4.  Acute inflammatory demyelinating polyneuropathy as a manifestation of chronic lymphoproliferative disorder of NK cells.

Authors:  Silvia Richelli; Romina Buono; Sergio Ferrari; Gaetano Vattemi; Salvatore Monaco
Journal:  Neurol Sci       Date:  2015-03-11       Impact factor: 3.307

Review 5.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

Review 6.  Intensive care unit-acquired weakness: implications for physical therapist management.

Authors:  Amy Nordon-Craft; Marc Moss; Dianna Quan; Margaret Schenkman
Journal:  Phys Ther       Date:  2012-01-26

7.  Hormonal status and ICU-acquired paresis in critically ill patients.

Authors:  Tarek Sharshar; Sylvie Bastuji-Garin; Bernard De Jonghe; Robert D Stevens; Andrea Polito; Virginie Maxime; Pablo Rodriguez; Charles Cerf; Hervé Outin; Philippe Touraine; Kathleen Laborde
Journal:  Intensive Care Med       Date:  2010-03-24       Impact factor: 17.440

8.  Treatment of refractory chronic inflammatory demyelinating polyneuropathy with interferon beta 1B.

Authors:  Eleonora Cocco; Elena Mamusa; Nicola Carboni; Giovanni Marrosu; Alessandro Vannelli; Maria Giuseppina Mascia; Antonella Sirca; Maria Giovanna Marrosu
Journal:  J Neurol       Date:  2005-06-20       Impact factor: 4.849

9.  Neurological examination of critically ill patients: a pragmatic approach. Report of an ESICM expert panel.

Authors:  Tarek Sharshar; Giuseppe Citerio; Peter J D Andrews; Arturo Chieregato; Nicola Latronico; David K Menon; Louis Puybasset; Claudio Sandroni; Robert D Stevens
Journal:  Intensive Care Med       Date:  2014-02-13       Impact factor: 17.440

10.  The physical function intensive care test: implementation in survivors of critical illness.

Authors:  Amy Nordon-Craft; Margaret Schenkman; Lara Edbrooke; Daniel J Malone; Marc Moss; Linda Denehy
Journal:  Phys Ther       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.